<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03879889</url>
  </required_header>
  <id_info>
    <org_study_id>01150077</org_study_id>
    <nct_id>NCT03879889</nct_id>
  </id_info>
  <brief_title>Smoking Reduction Intervention for Smoking Parents of Paediatric Patients in Hong Kong</brief_title>
  <official_title>Smoking Reduction Intervention for Smoking Parents of Paediatric Patients in Hong Kong: a Randomised Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chinese University of Hong Kong</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chinese University of Hong Kong</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      A randomized controlled trial to evaluate the effectiveness of smoking reduction
      interventions for smoking parents in paediatric hospital setting in Hong Kong.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a single blinded randomized controlled trial aiming to evaluate the effectiveness of
      smoking reduction interventions for smoking parents in paediatric hospital setting in Hong
      Kong. This trial consists of a 24-week intervention period. Eligible families will be
      randomly assigned to either intervention group or control group. Smoking parent(s) in
      intervention group will be given face-to-face counselling on smoking reduction and adherence
      to nicotine replacement therapy (NRT) with motivational interviews, provision of NRT and
      monthly phone follow-up for counselling and support. Smoking parent(s) in control group will
      be given standard advice and information on smoking cessation.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 1, 2017</start_date>
  <completion_date type="Anticipated">August 31, 2019</completion_date>
  <primary_completion_date type="Anticipated">July 31, 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>A single blinded randomized controlled trial aiming to evaluate the effectiveness of smoking reduction interventions for smoking parents in paediatric hospital setting in Hong Kong. This trial consists of a 24-week intervention period. Eligible families will be randomly assigned to either intervention group or control group. Smoking parent(s) in intervention group will be given face-to-face counselling on smoking reduction and adherence to nicotine replacement therapy (NRT) with motivational interviews, provision of NRT and monthly phone follow-up for counselling and support. Smoking parent(s) in control group will be given standard advice and information on smoking cessation.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
    <masking_description>Research study personnel who will conduct the data collection on outcome measures will be blinded to the group assignment. The researchers who will conduct the data analysis will also be blinded the group assignment.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Successful smoking reduction rate</measure>
    <time_frame>Week-24</time_frame>
    <description>successful smoking reduction rate is defined as a self-reported reduction of daily cigarette consumption by 50% or more compared with baseline</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in urinary cotinine levels of the children from baseline</measure>
    <time_frame>Week-24</time_frame>
    <description>Change in urinary cotinine levels of the children from baseline, indicating an objective measure of tobacco smoke exposure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Parental self-reported smoking reduction rate of cigarette consumption</measure>
    <time_frame>Week-24</time_frame>
    <description>Parental self-reported smoking reduction rate of cigarette consumption</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Parental self-reported smoking cessation rate of cigarette consumption</measure>
    <time_frame>Week-24</time_frame>
    <description>Parental self-reported 7-day point-prevalence tobacco abstinence</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Validated reduction and quit rate by parental urinary cotinine levels</measure>
    <time_frame>Week-24</time_frame>
    <description>Validated reduction and quit rate by parental urinary cotinine levels</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Validated quit rate by parental urinary cotinine levels</measure>
    <time_frame>Week-24</time_frame>
    <description>Validated quit rate by parental urinary cotinine levels</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Children's hospitalization rate</measure>
    <time_frame>Week-24</time_frame>
    <description>Children's hospitalization rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of children's respiratory tract infection episodes</measure>
    <time_frame>Week-24</time_frame>
    <description>Rate of children's respiratory tract infection episodes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of children's sick visits</measure>
    <time_frame>Week-24</time_frame>
    <description>Rate of children's sick visits</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Children's spirometric measurement - FEV1</measure>
    <time_frame>Week-24</time_frame>
    <description>Children's spirometric measurement - Forced expiratory volume in one second (FEV1)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Children's spirometric measurement - FVC</measure>
    <time_frame>Week-24</time_frame>
    <description>Children's spirometric measurement - Forced vital capacity (FVC)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">240</enrollment>
  <condition>Smoking, Tobacco</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intervention arm will include face-to-face counseling on smoking reduction and adherence to nicotine replacement therapy (NRT) with motivational interviews, provision of free NRT, referral to quit smoking hotline, monthly phone follow-up and two follow-up visits.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Smoking parents will be given standard advice on smoking cessation. They will be given an information leaflet showing standard information on the currently available smoking cessation service as well as a smoking cessation hotline.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nicotine patch</intervention_name>
    <description>Four weeks of nicotine patch will be provided at the first contact, which will be prescribed using the guidelines based on the subject's daily cigarette consumption. At week-4 visit, four more weeks of NRT will be provided.</description>
    <arm_group_label>Intervention</arm_group_label>
    <other_name>Nicotinelle</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Ethnic Chinese family with children aged younger than 18 years of age.

          -  Children who are admitted to the paediatric inpatient units or attend the paediatric
             specialist clinic at the Prince of Wales Hospital.

          -  Children with at least one custodial smoking parent who is living with them.

          -  Written informed consent obtained from parents.

        Exclusion Criteria:

          -  Families not residing in Hong Kong.

          -  Children in foster care.

          -  Children with unclear custody.

          -  Smoking paediatric patients.

          -  Presence of smoking household members apart from the parents.

          -  Smoking parent who is contraindicated to use nicotine replacement therapy.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ching Ching Chan, FHKAM</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chinese University of Hong Kong</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ching Ching Chan, FHKAM</last_name>
    <phone>35052849</phone>
    <email>katechan@cuhk.edu.hk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Prince of Wales Hospital</name>
      <address>
        <city>Hong Kong</city>
        <country>Hong Kong</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ching Ching Chan, FHKAM</last_name>
      <phone>35052849</phone>
      <email>katechan@cuhk.edu.hk</email>
    </contact>
    <investigator>
      <last_name>Ching Ching Chan, FHKAM</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Albert M Li, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Hong Kong</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>March 13, 2019</study_first_submitted>
  <study_first_submitted_qc>March 14, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 19, 2019</study_first_posted>
  <last_update_submitted>March 14, 2019</last_update_submitted>
  <last_update_submitted_qc>March 14, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 19, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chinese University of Hong Kong</investigator_affiliation>
    <investigator_full_name>Kate Ching Ching Chan</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Smoking reduction</keyword>
  <keyword>Randomised controlled trial</keyword>
  <keyword>Motivational interview</keyword>
  <keyword>Nicotine replacement therapy</keyword>
  <keyword>Environmental tobacco smoke exposure</keyword>
  <keyword>Paediatrics</keyword>
  <keyword>Children</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nicotine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

